// App-Quantinova.ai

3773 : Preclinical evaluation of the CDK4/6 inhibitor LEE011 in nasopharyngeal carcinoma (NPC) cell lines

Researchers

Presenter

  • Brigette B. Ma

Principal Investigators

  • Chi-Hang Wong

  • Connie Hui

  • Edwin P. Hui

  • Anthony T.C. Chan

Medical Centers

  • Chinese Univ. of Hong Kong, Shatin, NT, Hong Kong

Locations

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Nasopharyngeal carcinoma

  • Solid malignancies

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Cyclin D1

  • Cyclin dependent kinase 6

Drug/Treatment

  • Cisplatin

  • Alpelisib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved